Academic Journal

Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial

التفاصيل البيبلوغرافية
العنوان: Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial
المؤلفون: Kolberg-Liedtke, Cornelia, Feuerhake, Friedrich, Garke, Madlen, Christgen, Matthias, Kates, Ronald, Grischke, Eva Maria, Forstbauer, Helmut, Braun, Michael, Warm, Mathias, Hackmann, John, Uleer, Christoph, Aktas, Bahriye, Schumacher, Claudia, Kuemmel, Sherko, Wuerstlein, Rachel, Graeser, Monika, Nitz, Ulrike, Kreipe, Hans, Gluz, Oleg, Harbeck, Nadia
سنة النشر: 2022
المجموعة: University of Duisburg-Essen: DuEPublico (Duisburg Essen Publications online)
مصطلحات موضوعية: ScholarlyArticle, ddc:610, Medizinische Fakultät » Universitätsklinikum Essen » Klinik für Frauenheilkunde und Geburtshilfe, Medizinische Fakultät » Universitätsklinikum Essen » Kliniken Essen-Mitte, Triple-negative breast cancer -- sTils -- Neoadjuvant chemotherapy -- Pathologic complete response -- 3-Week biopsy
الوصف: Background: Higher density of stromal tumor-infiltrating lymphocytes (sTILs) at baseline has been associated with increased rates of pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC). While evidence supports favorable association of pCR with survival in TNBC, an independent impact of sTILs (after adjustment for pCR) on survival is not yet established. Moreover, the impact of sTIL dynamics during NACT on pCR and survival in TNBC is unknown. Methods: The randomized WSG-ADAPT TN phase II trial compared efficacy of 12-week nab-paclitaxel with gemcitabine versus carboplatin. This preplanned translational analysis assessed impacts of sTIL measurements at baseline (sTIL-0) and after 3 weeks of chemotherapy (sTIL-3) on pCR and invasive disease-free survival (iDFS). Predictive performance of sTIL-0 and sTIL-3 for pCR was quantified by ROC analysis and logistic regression; Kaplan–Meier estimation and Cox regression (with mediation analysis) were used to determine their impact on iDFS. Results: For prediction of pCR, the AUC statistics for sTIL-0 and sTIL-3 were 0.60 and 0.63, respectively, in all patients; AUC for sTIL-3 was higher in NP/G. The positive predictive value (PPV) of “lymphocyte-predominant” status (sTIL-0 ≥ 60%) at baseline was 59.3%, though only 13.0% of patients had this status. To predict non-pCR, the cut point sTIL-0 ≤ 10% yielded PPV = 69.5% while addressing 33.8% of patients. Higher sTIL levels (particularly at 3 weeks) were independently and favorably associated with better iDFS, even after adjusting for pCR. For example, the adjusted hazard ratio for 3-week sTILs ≥ 60% (vs. < 60%) was 0.48 [0.23–0.99]. Low cellularity in 3-week biopsies was the strongest individual predictor for pCR (in both therapy arms), but not for iDFS. Conclusion: The independent impact of sTILs on iDFS suggests that favorable immune response can influence key tumor biological processes for long-term survival. The results suggest that the reliability of pCR ...
نوع الوثيقة: article in journal/newspaper
اللغة: English
Relation: https://doi.org/10.1186/s13058-022-01552-w; https://nbn-resolving.org/urn:nbn:de:hbz:465-20240205-151435-4; https://duepublico2.uni-due.de/receive/duepublico_mods_00078974; https://duepublico2.uni-due.de/servlets/MCRFileNodeServlet/duepublico_derivate_00081030/Breast_Cancer_Res_2022_24_58.pdf
DOI: 10.1186/s13058-022-01552-w
الاتاحة: https://doi.org/10.1186/s13058-022-01552-w
https://nbn-resolving.org/urn:nbn:de:hbz:465-20240205-151435-4
https://duepublico2.uni-due.de/receive/duepublico_mods_00078974
https://duepublico2.uni-due.de/servlets/MCRFileNodeServlet/duepublico_derivate_00081030/Breast_Cancer_Res_2022_24_58.pdf
Rights: https://creativecommons.org/licenses/by/4.0/ ; info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.9B45B53A
قاعدة البيانات: BASE
الوصف
DOI:10.1186/s13058-022-01552-w